You are about to access information on our medicines and medical devices aimed exclusively at healthcare professionals.

By virtue of Spanish Royal Decree 1416/1994 of 25 June regulating the advertising of medicinal products for human use, Spanish Royal Decree 1591/2009 of 16 October regulating medical devices and Law 29/2006 of 26 July on the guarantees and rational use of medicines and health products, in this section Bioiberica can only offer advertising content of prescription medicines to health personnel authorised to prescribe or dispense them.

I am a health professional authorised to prescribe or dispense, or a pharma company professional.

You are here

Bioiberica Heparin Science to launch a new website dedicated to the heparin molecule

1 Jul 2019
  • This online asset has a double aim: to offer information on the business unit, and to concentrate in a single place scientific, historical and general public information on heparin
  • Heparin is the most commonly used medicine for the prevention and treatment of thrombosis, and it is included in the list of essential medicines of the World Health Organization (WHO)
  • Bioiberica is a leading producer of the heparin API worldwide

Bioiberica Heparin Science has launched a website dedicated to the heparin molecule. This is a new online asset offering information on the business unit concentrating, in a single space, scientific and historical information, as well as disseminating the latest research on this active pharmaceutical ingredient.

This new website has a clean, state-of-the-art, completely responsive design, contains rigorous and evidence-based information, and aims to be a reference in their sector. “Since the foundation of Bioiberica, in 1975, our company put the focus on the production of heparin. This molecule is truly unique, due to their complexity and heterogeneous composition. In all these years, Bioiberica has gained in-depth knowledge of their production, thus offering the highest safety, quality and traceability standards. This specialized know-how is what we want to share in our new website” explained Joan Bassa, director at Bioiberica Heparin Science.

This new site is part of Bioiberica’s digital communication strategy-in the current year, we have launched a new corporate website and a site for our Plant Health business unit.

Heparin is the most commonly used medicine for thrombosis prevention and treatment, and it is included in the list of essential medicines of the WHO.

Bioiberica Heparin Science is a global leader in the production, marketing and research of the pharmaceutical active ingredient heparin. Our company has eight processing plants around the world, thus guaranteeing the fully traceability and high quality standards of the entire production process. Our product can be traced through their entire production and life span, thus minimizing any biological risks.

Related News

28 Sep 2021

The 28th Symposium on Glycosaminoglycans, an internationally renowned scientific event focusing on glycosaminoglycans, will be sponsored by

4 Aug 2021
  • Bioiberica produces 20% of the world's Heparin API.
  • Heparin saves around a hundred million lives every year.
  • One out of every 5 doses of heparin administered in the world comes from Bioiberica.
2 Aug 2021
  • One of every 5 doses of heparine administered in the world comes from Bioiberica.
  • Several studies indicate that people hospitalized treated with anticoagulants, improved their chances of survival.